Fig. 3From: CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axisCircCRIM1 promotes the growth of ovarian cancer in vivo. The group that upregulated circCRIM1 had more bulky tumor volume compared to vector group (a and b). Data are shown as the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001Back to article page